As the global HLA Typing market continues to increase in demand, the number of new commercial vendors focusing on HLA Typing has stayed fairly flat relative to growth. In a new market research study conducted by Data Bridge Market Research, the global HLA Typing market is set to grow to $1.05B in 2025, up from $532M in 2017, representing a 9% CAGR. While the dominant method for HLA Typing today is still PCR based, Next Generation Sequencing (NGS) has experienced significant growth at 9.6% CAGR due to better quality of data, higher resolution sequencing, and more affordable pricing.
HLA Typing continues to be a critical data point required in many research areas, such as immune system analysis or host-donor organ transplants. While previous methods relied on fundamental mendelian genetics, Next Generation Sequencing provides deep optics into genetic structures within samples, creating a more empirical and data driven research process. This is considered the superior method due to high resolution HLA Typing, giving researchers a view into novel variants or known variants from a crowd sourced database, such as the IMGT Database. As outlined in the study, the benefits of HLA Typing continue to grow in importance within clinical research.
Within the study, The Sequencing Center was included as a top vendor option to choose from. While relatively new to the market, The Sequencing Center has made incredible strides in increasing their market share against incumbent competitors. This is due to the aggressive pricing, quality data, and rapid turnaround time that they promise – all variables that currently plague the field. With an HLA Typing revenue growth exceeding 30% quarter over quarter, The Sequencing Center is poised to continue to capture market share. Additionally, as they start to commoditize additional services (eg. DNA Extraction and Bioinformatics), they plan on expanding their pipeline to include integrated and comprehensive testing services to accompany HLA Typing, creating a true all-in-one service that clinicians and drug discovery researchers can rely on.
The full report can be found here.